Debreceno vaistinė
UAB „Debreceno vaistinė“ was established on the 5th of November, 1993. Company’s main activity is medicines production and sale.
Financial results
P/L Statment
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Revenue | 573 | 691 | 762 | 817 |
| Cost of goods sold | 339 | 407 | 456 | 478 |
| Gross profit (loss) | 234 | 284 | 306 | 339 |
| Gross profit margin | 41% | 41% | 40% | 41% |
| Operating expenses | 80 | 109 | 114 | 126 |
| Operating profit (loss) | -8 | -9 | -2 | 4 |
| Operating profit margin | -1% | -1% | -0% | 0% |
| EBITDA | 3 | 14 | 25 | 36 |
| EBITDA margin | 0% | 2% | 3% | 4% |
| Net profit (loss) | 1 | 2 | 11 | 18 |
| Net profit margin | 0% | 0% | 1% | 2% |
Balance sheet
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Non-current assets | 511 | 502 | 509 | 506 |
| Intangible assets | ||||
| Tangible assets | 511 | 502 | 492 | 494 |
| Financial assets | ||||
| Other non-current assets | 17 | 12 | ||
| Current assets | 71 | 81 | 82 | 89 |
| Inventories and prepaid expenses | 47 | 47 | 55 | 61 |
| Accounts receivable in one year | 21 | 22 | 17 | 23 |
| Other current assets | ||||
| Cash and cash equivalents | 3 | 12 | 10 | 4 |
| Total assets | 583 | 584 | 591 | 595 |
| Equity | 546 | 548 | 556 | 569 |
| Grants and subsidies | ||||
| Liabilities | 36 | 36 | 35 | 27 |
| Financial liabilities | 0 | 0 | 0 | 0 |
| Long-term liabilities | ||||
| Short-term liabilities | 36 | 36 | 35 | 27 |
| Equity and liabilities | 583 | 584 | 591 | 595 |
Financial ratios
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Capital return ratios | ||||
| Return on assets (ROA) | 0% | 0% | 2% | 3% |
| Return on equity (ROE) | 0% | 0% | 2% | 3% |
| Return on capital employed (ROCE) | -1% | -2% | -0% | 1% |
| Capital structure and liquidity ratios | ||||
| Debt / asset ratio (D/A) | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 1.96 | 2.28 | 2.37 | 3.34 |
| Quick ratio | 0.65 | 0.97 | 0.79 | 1.04 |
| Turnover ratios | ||||
| Asset turnover | 0.98 | 1.18 | 1.29 | 1.37 |
| Fixed asset turnover | 1.12 | 1.38 | 1.50 | 1.61 |
| Equity turnover | 1.05 | 1.26 | 1.37 | 1.44 |
| Profitability ratios | ||||
| EBITDA margin | 0% | 2% | 3% | 4% |
| Operating profit margin | -1% | -1% | -0% | 0% |
| Net profit margin | 0% | 0% | 1% | 2% |
| Other ratios | ||||
| Dividends to the Municipality | 1.00 | 1.00 | 3.77 | 4.17 |
| Dividends paid / net profit | 0.77 | 0.40 | 0.35 | 0.24 |
Expectations of the municipal
About the company
- Official nameUAB „Debreceno vaistinė“
- Legal formPrivate limited liability company (UAB)
- Company code140786882
- SectorOther
- Line of businessPharmacy activities
- Representing institutionKlaipėda city municipality
- Share belonging to the Municipal100%
- Contacts https://www.debreceno-vaistine.lt/
Return to the Municipality
4 EUR thousand
ROE
3.2%
Number of employees
14
Financial data provided as at end-December 2024
Management
- Justinas ŠčėsnaChief Executive Officer
Information as of: 2025/06/01
